Connexa Regains Full Nasdaq Compliance
Connexa Receives Nasdaq Confirmation Bid Price Hearing Panel Cancelation, and Delisting Determination Withdrawn. Following June 27, 2024 Reverse Split and […]
Exela Technologies and AIDEO Technologies Enter Strategic Alliance
IRVING, Texas, July 22, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA, XELAP), a leader in business […]
NANO Nuclear Energy Appoints Distinguished Nuclear Regulatory Expert David Tiktinsky as Head of Nuclear Regulatory Licensing after nearly 40-years with the Nuclear Regulatory Commission (NRC)
Tiktinsky’s nearly 40 years of experience at the U.S. Nuclear Regulatory Commission to greatly assist NANO Nuclear in navigating the […]
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer […]
HeartCore to Authorize Second Dividend Payment
NEW YORK and TOKYO, July 22, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
Open Lending to Announce Second Quarter 2024 Results on August 8, 2024
AUSTIN, Texas, July 22, 2024 (GLOBE NEWSWIRE) — Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or “the Company”), an industry […]
CSW Industrials Announces Date for Fiscal First Quarter 2025 Earnings Release Conference Call
DALLAS, July 22, 2024 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (NASDAQ: CSWI) announced that it will release its earnings results […]
Willis Lease Finance Corporation Hires SR Technics Veteran, Caroline M. Vandedrinck, to Run its Growing Services Businesses
COCONUT CREEK, Fla., July 22, 2024 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the […]
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports
Study adds to the Company’s growing body of evidence and expands the understanding of the regulatory capabilities of its DHACM […]
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
CORAL GABLES, Fla., July 22, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage [...]
